Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Porcine viral diarrhea is a common and frequently-occurring disease in pigs, and the most serious pathogens are porcine transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV) and porcine rotavirus (PoRV). All three pathogens can infect pigs of all ages and can cause symptoms such as vomiting, watery diarrhea and dehydration. The harm to piglets within 10 days of age is particularly serious, and the morbidity and mortality are high, up to 100%. The vaccine is inoculated at the Houhai point, and it is safe and effective for all pigs including suckling piglets and pregnant sows. It realizes the prevention of three diseases with one shot, reduces the immune stress of pigs, and reduces the labor intensity and breeding of vaccination. cost, and has a significant effect on the prevention of single infection or mixed infection of the three pathogens.

This report is a detailed and comprehensive analysis for global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Santé Animale and MSD Animal Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Live Vaccine
Inactivated Vaccine

Market segment by Application
Piglets
Adults Pigs

Major players covered
Zoetis Animal Health
Boehringer-Ingelheim
Merck Animal Health
Ceva Santé Animale
MSD Animal Health
SPAH
Nanjing Tianbang Biological Technology
Sichuan Huapai Bio-pharmaceutical
Guangdong Winsun Bio Pharmaceutical
Wuhan Keqian Biology
Shanghai Hile Bio-Technology
Harbin Pharmaceutical Group Bio-Vaccine
Ringpu
Shandong Huahong Bioengineering
Weike Biotechnology
Nanjing Tianbang Biological Technology
China Animal Husbandry Industry

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, with price, sales, revenue and global market share of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine from 2018 to 2023.

Chapter 3, the Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine.

Chapter 14 and 15, to describe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion.